Your browser doesn't support javascript.
loading
CX3CL1 at the crossroad of EGF signals: Relevance for the progression of ERBB2+ breast carcinoma.
Tardáguila, Manuel; Mañes, Santos.
Afiliação
  • Tardáguila M; Department of Immunology and Oncology; Centro Nacional de Biotecnología/CSIC; Madrid, Spain.
Oncoimmunology ; 2(9): e25669, 2013 Sep 01.
Article em En | MEDLINE | ID: mdl-24319638
ABSTRACT
Inflammatory mediators can play a dual role in oncogenesis and tumor progression. CX3CL1, a chemokine previously implicated in natural killer cell- and CD8+ T cell-mediated antitumor immune responses, has now been identified as a promoter of ERBB2-expressing breast carcinomas as it cross-activates members of the epidermal growth factor receptor family.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Oncoimmunology Ano de publicação: 2013 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Oncoimmunology Ano de publicação: 2013 Tipo de documento: Article